SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-016908
Filing Date
2022-11-08
Accepted
2022-11-08 16:57:13
Documents
68
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q ptgx-20220930x10q.htm   iXBRL 10-Q 1977921
2 EX-31.1 ptgx-20220930xex31d1.htm EX-31.1 10125
3 EX-31.2 ptgx-20220930xex31d2.htm EX-31.2 10149
4 EX-32.1 ptgx-20220930xex32d1.htm EX-32.1 9543
5 GRAPHIC ptgx-20220930x10q007.jpg GRAPHIC 86850
  Complete submission text file 0001558370-22-016908.txt   7905438

Data Files

Seq Description Document Type Size
6 EX-101.SCH ptgx-20220930.xsd EX-101.SCH 55697
7 EX-101.CAL ptgx-20220930_cal.xml EX-101.CAL 47414
8 EX-101.DEF ptgx-20220930_def.xml EX-101.DEF 229347
9 EX-101.LAB ptgx-20220930_lab.xml EX-101.LAB 418650
10 EX-101.PRE ptgx-20220930_pre.xml EX-101.PRE 355192
62 EXTRACTED XBRL INSTANCE DOCUMENT ptgx-20220930x10q_htm.xml XML 1400507
Mailing Address 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160
Business Address 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160 (510) 474-0170
Protagonist Therapeutics, Inc (Filer) CIK: 0001377121 (see all company filings)

IRS No.: 980505495 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37852 | Film No.: 221369717
SIC: 2834 Pharmaceutical Preparations